Baldwin Wealth Partners’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Baldwin Wealth Partners's RMD Position: Q3 2026 in Review
Baldwin Wealth Partners reduced its ResMed (RMD) stake by 13% in Q3 2026, selling an estimated $106K and leaving 3,183 shares worth $704K. The position accounts for 0.05% of the portfolio, ranked #125.
Baldwin Wealth Partners first reported a position in RMD in Q1 2020 and has held it in 27 quarters since. The position peaked at $2.83M in Q1 2023. 288 funds tracked by Wall St. Rank hold RMD as of Q3 2026.
- Baldwin Wealth Partners held 3,183 shares of ResMed worth $704K as of Q3 2026.
- Baldwin Wealth Partners sold 485 ResMed shares in Q3 2026, an estimated $106K.
- ResMed made up 0.05% of Baldwin Wealth Partners's portfolio in Q3 2026, its #125 holding.
- Baldwin Wealth Partners first reported a position in ResMed in Q1 2020 and has held it in 27 quarters since.
- Baldwin Wealth Partners's ResMed position peaked at $2.83M in Q1 2023.
- 288 funds tracked by Wall St. Rank held ResMed as of Q3 2026.
Based on Baldwin Wealth Partners's 13F filing for Q3 2026, filed 13 Oct 2026.